Clinical Trial Update: Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed the safety and effects of 5 mg and 10 mg oral SLx-2101 given for 14 days in patients with hypertension; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• SLx-2101

Snippet

Sponsor: Response Pharmaceuticals | Conditions: Hypertension | Phase 2 | Status: COMPLETED